Copertina

Assessing heterogeneity in surrogacy using censored data

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Layla Parast, Lu Tian, Tianxi Cai
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Statistics in Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Model‐Free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival
di: Xuan Wang, et al.
Pubblicazione: (2025)

A General Framework to Assess Complex Heterogeneity in the Strength of a Surrogate Marker
di: Rebecca Knowlton, et al.
Pubblicazione: (2025)

Erratum to “Joint modeling for censored predictors due to detection limits with applications to metabolites data”
Pubblicazione: (2024)

Distributional imputation for the analysis of censored recurrent events
di: Sarah R. Fairfax, et al.
Pubblicazione: (2024)

Improving Efficiency and Robustness of the Prognostic Accuracy of Biomarkers With Partial Incomplete Failure‐Time Data and Auxiliary Outcome: Application to Prostate Cancer Active Surveillance Study
di: Yunro Chung, et al.
Pubblicazione: (2025)

τ$$ \tau $$‐Inflated beta regression model for censored recurrent events
di: Yizhuo Wang, et al.
Pubblicazione: (2024)

Variance‐components tests for genetic association with multiple interval‐censored outcomes
di: Jaihee Choi, et al.
Pubblicazione: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
di: Luana Boumendil, et al.
Pubblicazione: (2024)

Information‐incorporated sparse hierarchical cancer heterogeneity analysis
di: Wei Han, et al.
Pubblicazione: (2024)

Modeling multiple‐criterion diagnoses by heterogeneous‐instance logistic regression
di: Chun‐Hao Yang, et al.
Pubblicazione: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
di: Carly Lupton Brantner, et al.
Pubblicazione: (2024)

Response
di: Layla Parast, et al.
Pubblicazione: (2024)

Generalized single index modeling of longitudinal data with multiple binary responses
di: Zibo Tian, et al.
Pubblicazione: (2024)

Model-free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival
di: Wang, Xuan, et al.
Pubblicazione: (2024)

Survival causal rule ensemble method considering the main effect for estimating heterogeneous treatment effects
di: Ke Wan, et al.
Pubblicazione: (2024)

Estimation and reduction of bias in self‐controlled case series with non‐rare event dependent outcomes and heterogeneous populations
di: Kenneth Menglin Lee, et al.
Pubblicazione: (2024)

A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight
di: Zihan Qian, et al.
Pubblicazione: (2025)

A sparse factor model for clustering high‐dimensional longitudinal data
di: Zihang Lu, et al.
Pubblicazione: (2024)

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
di: Konstantinos Sechidis, et al.
Pubblicazione: (2025)

A New Test for Assessing the Covariate Effect in ROC Curves
di: Arís Fanjul‐Hevia, et al.
Pubblicazione: (2025)

Using Causal Diagrams to Assess Parallel Trends in Difference‐in‐Differences Studies
di: Audrey Renson, et al.
Pubblicazione: (2026)

An Information Criterion Approach for Assessing Agreement When Comparing Two Methods of Measurement
di: Charles Y. Tan, et al.
Pubblicazione: (2025)

Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models
di: Yao Chen, et al.
Pubblicazione: (2026)

Mediation analysis using incomplete information from publicly available data sources
di: Andriy Derkach, et al.
Pubblicazione: (2024)

Synergy Area With FDR ‐Controlled Evaluation ( SAFE ) to Robustly Assess Safety Profile in Clinical Trials
di: Tianyu Zhan, et al.
Pubblicazione: (2026)

Bayesian Hierarchical Models With Calibrated Mixtures of g‐priors for Assessing Treatment Effect Moderation in Meta‐Analysis
di: Qiao Wang, et al.
Pubblicazione: (2026)

Approximate maximum likelihood estimation in cure models using aggregated data, with application to HPV vaccine completion
di: John D. Rice, et al.
Pubblicazione: (2024)

Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?
di: Matthew Dodd, et al.
Pubblicazione: (2024)

Sequential Parallel Comparison Design for Assessing Induction, Maintenance, Long‐Term, and Other Treatment Effects on a Binary Endpoint
di: Hui Quan, et al.
Pubblicazione: (2026)

Partially Linear Additive Quantile Regression: Theory and Applications to Breast Cancer Patients' Survival
di: Xinyi Zhao, et al.
Pubblicazione: (2026)

A latent variable approach to jointly modeling longitudinal and cumulative event data using a weighted two‐stage method
di: Madeline R. Abbott, et al.
Pubblicazione: (2024)

Optimal subsampling for semi‐parametric accelerated failure time models with massive survival data using a rank‐based approach
di: Zehan Yang, et al.
Pubblicazione: (2024)

Assessing Treatment Effects in Observational Data With Missing Confounders: A Comparative Study of Practical Doubly‐Robust and Traditional Missing Data Methods
di: Brian D. Williamson, et al.
Pubblicazione: (2026)

Efficient matrix profile computation with Euclidean distance using Eigen transformation: Performance evaluation based on beat‐to‐beat interval (BBI) data
di: James J. Yang, et al.
Pubblicazione: (2024)

Statistical methods for predicting e‐cigarette use events based on beat‐to‐beat interval (BBI) data collected from wearable devices
di: James J. Yang, et al.
Pubblicazione: (2024)

Optimal model averaging for partially linear models with missing response variables and error‐prone covariates
di: Zhongqi Liang, et al.
Pubblicazione: (2024)

Using Propensity Score Weighting With Clustered Data When the Treatment Is Applied at the Level of the Cluster and Outcomes Are Assessed at the Level of the Individual: The Observational Analog of Cluster Randomization Trials
di: Peter C. Austin
Pubblicazione: (2026)

RMST for Interval‐Censored Data in Oncology Clinical Trials
di: Xiyuan Gao, et al.
Pubblicazione: (2025)

Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies
di: Dadong Zhang, et al.
Pubblicazione: (2024)

Random Survival Forest With Multiple Imputation Analysis for Case‐Cohort and Generalized Case‐Cohort Studies
di: Haolin Li, et al.
Pubblicazione: (2025)